mitoxantrone has been researched along with Bladder Diseases in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giannakopoulos, S | 1 |
| Pantazis, T | 1 |
| Kalaitzis, C | 1 |
| Antoniou, D | 1 |
| Patris, E | 1 |
| Touloupidis, S | 1 |
1 other study available for mitoxantrone and Bladder Diseases
| Article | Year |
|---|---|
Severe bladder contracture leading to cystectomy after intravesical mitoxantrone chemotherapy.
Topics: Administration, Intravesical; Aged; Antineoplastic Agents; Contracture; Cystectomy; Female; Humans; | 2008 |